This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Jianlin (Jim) Xu, PhD
Scientific Director, Biologics Development at Bristol-Myers Squibb


Dr. Jianlin (Jim) Xu is a Scientific Director in Global Upstream and Cell Line Development Department within Biologics Development at Bristol Myers Squibb (BMS), USA. Jim has worked at BMS for 16 years. Jim is a highly motivated professional with an educational background in both science and engineering. He has a 30 years’ experience in people management, process development, tech-transfer, biomanufacturing technologies, and regulatory filing for biologics CMC development at different clinical stages as well as life cycle management at multiple internal and external GMP facilities covering various scales (up to 20,000-L) for biological products in USA, Europe, and China. Those biological products span mAbs, fusion proteins, bispecific, AAV vectors, vaccines, natural products, prebiotics/probiotics, and organic acids. In addition, Jim has demonstrated a proven track record on scientific research with 5 patents and 25 publications in upstream process development and manufacturing for last 5 years.

Agenda Sessions

  • Keynote Address – Upstream Process Development and Manufacturing at Pandemic Speed